Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches - Wikidata - awgldk - TriplyDB

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

http://www.wikidata.org/entity/Q26821926

about

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma Cohort profile: cholangiocarcinoma screening and care program (CASCAP).A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.Liver transplantation for hepatolithiasis: Is terminal hepatolithiasis suitable for liver transplantation?Liver fluke infection and cholangiocarcinoma: a review.Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI.Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma.Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis.Highlights of topic "Biochemical and molecular pathological aspects of cholangiocarcinoma"

P2860

Q26784091-A85AA203-C5FF-4EC3-B477-2159D7BCD313 Q35693985-26507CE1-90E8-4FA9-B025-831744AEFD60 Q35900738-877B7C61-288A-4C42-84EA-34ECC105C9BA Q38762439-0E2B1286-2CB0-406C-8403-74EE1CD560B8 Q38975511-C9E4ACD8-E81F-4910-B1DD-15F186E2B800 Q41387451-DAAD961E-2F18-4303-A9F8-DCF8681AF39D Q50999536-778D0A31-C8D2-4143-989C-01031EC4CEAF Q55248371-00708264-B5E8-4454-B7ED-BDD38F338045 Q57152211-5C6C3701-5189-4B17-AA11-A06EAC4A8CC1

P2860

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

http://www.wikidata.org/entity/Q26821926

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@ast

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@en

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@nl

type

label

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@ast

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@en

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@nl

prefLabel

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@ast

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@en

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@nl

P1433

Q26821926-BF6CC0ED-33B2-4BF2-8AC9-C63E6CD6B266

P1476

Q26821926-69477E3C-FE25-4702-8D4E-EEBD6B424F0E

P2093

Q26821926-1107A176-7324-4F87-9F23-4901FC3CF6C1

Q26821926-118EA0DD-517B-4215-9C42-1625091847C5

Q26821926-37091261-9BED-4125-BC1A-2AF6458DDB47

Q26821926-63E6C751-3DCD-4ACE-8D88-124C8431F812

P2860

Q26821926-1E45C8CC-F15D-4AC2-8A2B-F28464A724E5

Q26821926-20568AA7-A861-45CC-852E-8FB0EB203E60

Q26821926-256A46F5-5D36-4816-A9EF-FB072105AF28

Q26821926-2F1CD7E0-771B-4AFB-8E5C-799E09619388

Q26821926-3135EAD6-D77F-4219-9F93-2307AB5F2F0B

Q26821926-483688A5-620E-4F79-86E1-42AB8D3FE433

Q26821926-52CEBE31-C8C3-4EC6-9304-2EF4873C17C2

Q26821926-56A58599-2A4B-4CD1-8953-EECD4873EC0B

Q26821926-57104C75-58B5-44B6-8792-532DAF0715CE

Q26821926-572E63EE-4909-4283-ABB6-9845A45F578F

P304

Q26821926-CDACD4D4-7472-4ED3-82EA-90158244E2B4

P31

Q26821926-2324A50D-B15D-4148-A3E0-A7DCEC7D4811

P356

Q26821926-070EFC89-5D9C-41D0-AAEE-8858D3627A07

P407

Q26821926-FB8E0CC7-4FCD-46EA-8A06-E105C7093289

P433

Q26821926-66FCBBFD-64E9-47CC-9DF4-D7F06BD6260B

P478

Q26821926-2F6FE511-1BE7-413D-B128-8776C4EC186B

P577

Q26821926-7642BDF7-C2E1-4B9D-98A7-3B110293F713

P698

Q26821926-65CEB0A9-FDA5-4742-8882-7750AF02FF30

P921

Q26821926-391DF479-B503-4EE2-8666-07F6DFBD2A2C

Q26821926-5D11AB37-11E7-4205-B01E-073CC10F5182

P932

Q26821926-A39D01DC-599B-4615-8D6E-8062323D44D1

P356

P1433

Journal of Hepato-biliary-Pancreatic Sciences

P1476

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

@en

P2093

Atit Silsirivanit

http://www.w3.org/2001/XMLSchema#string

Chaisiri Wongkham

http://www.w3.org/2001/XMLSchema#string

Gregory J. Riggins

http://www.w3.org/2001/XMLSchema#string

Kanlayanee Sawanyawisuth

http://www.w3.org/2001/XMLSchema#string

P2860

A proteomic analysis of human bile

A high confidence, manually validated human blood plasma protein reference set

Proteomic analysis of cholangiocarcinoma cell line.

Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.

Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma.

Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma.

Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes

Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

P304

388-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JHBP.68

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24616382

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

4322866

http://www.w3.org/2001/XMLSchema#string